Each year at this time I start thinking about what the next year will bring for the stem cell field and make predictions. This year is no different and I’ve been pondering what 2012 has in store for us. You can read my predictions for 2011 here and see how I fared. Not too bad, but overly optimistic […]
Stem cell predictions for 2012: Science, CIRM, ACT, trends Read More »
Yesterday Geron announced it would be immediately stopping its stem cell research program. What does this mean? While this program has (or should I say “had”) a number of elements, at its heart was of course its hESC-based OPC drug (GRNOPC1) for spinal cord injury, which was in an FDA-approved Phase I Clinical Trial that
The day after Geron news: a realistic outlook for the stem cell field Read More »
Many of you may have heard that there is a Vatican stem cell meeting . Today the Vatican held the first day of its adult stem cell conference. Embryonic stem cells remained not surprisingly uninvited. This conference is an unprecedented event in the thousands of years of history of The Church so not surprisingly many
What are the goals of the Vatican stem cell meeting and why no press releases so far? Read More »
What with the Mississippi “personhood” amendment up for a vote today and also the Vatican Adult Stem Cell Conference beginning tomorrow, I thought today was a good time for a post about adult versus embryonic stem cells. Does stem cell research have to be either/or? Adult or stem? Can’t someone be for both adult and
Key points about adult versus embryonic stem cells Read More »
What is Myc? Often when we dig a little into the science of stem cells, people get turned off by all the strange names of molecules and jargon. However, whether you are a scientist, patient, investor, reporter, etc. there are some aspects of stem cell science that are ‘musts’ to know about. For example, you
Want to understand stem cells? Then you have to know Myc Read More »
As many of you know, I did a post this week on an article in The New Scientist that many readers had complained to me about. Their concerns and mine as well centered on two points. First, the article seemed at a factual level to be confusing and written in a People Magazine-esque style that
More on The New Scientist and stem cells Read More »
In mid-November the Catholic Church, in fact the Vatican itself, will do something it has never done before in its very long existence. It will hold a conference on stem cells. Perhaps equally unusual and of interest is the fact that the basis for this conference is a $1 million (USD) gamble by the Vatican
More on the Vatican $1 million gamble on NeoStem and their upcoming conference in Rome Read More »
Why does it worry me that the Vatican is having a stem cell conference? One of the hallmarks of Democracy is separation of church and state. When states mix religion into politics and government, the results have during human history been disastrous. Equally dismal has been the relationship between religion and science. Ever since the
The Vatican Stem Cell Meeting…is mixing religion and science a good idea? Read More »
Stem cell sports medicine is emerging as a new area of medicine. As the list of star athletes and other celebs that have received dubious stem cell treatments grows longer, I don’t think there is any question but that this turn of events will be the spark that drives hundreds of ordinary people to get
Stem cell sports medicine: a miraculous or disastrous combo? Read More »
There has been concern for months about the direction that the European Union was heading in regards to intellectual property (IP) rights and stem cell patent approaches. Now, a definitive decision banning embryonic stem cell (ESC)-based patents by the EU Court has dealt a severe blow to stem cell science in Europe. The European Court
Anti-cure impact of Errant EU stem cell patent decision Read More »